News

The Phase I SBI-087 dose escalation clinical trial is designed to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of SBI-087 in patients with rheumatoid

While the initial new drug application (NDA) submission qualified for a priority review, certain technical issues around data presentation prevented a complete evaluation by the FDA within the

But the study did not demonstrate a statistically significant prolongation of overall survival, a secondary endpoint, for either dose in combination with gemcitabine and cisplatin chemotherapy compared to

The term sheet includes certain worldwide cross-licenses under which each party receives a royalty-free license under all existing patents of the other party for its respective existing capsule

Sanofi Pasteur, the vaccines division of Sanofi-Aventis, plans to invest C$100 million in a state-of-the-art facility at the company’s Connaught Campus in north Toronto, Canada. The Government of

In the first-quarter 2008, Norvasc and Zyrtec revenues decreased by $556 million and $344 million, respectively, compared with the same quarter of 2007. For the first-quarter 2008, Pfizer

The agreement grants Echo exclusive rights of first negotiation to all dermatology product and transdermal drug delivery technology opportunities identified or acquired by Cato BioVentures. Patrick Mooney, Echo’s

Nimodipine soft gel capsules are the generic equivalent of Nimotop capsules marketed by Bayer. Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and

Under the agreement, Vernalis will receive approximately E18.4 million in cash from Paul Capital Healthcare and, in return, Paul Capital Healthcare will receive approximately 90% of Menarini’s payments